SU YEUN CHANG: Open Payments
NPI 1922764083 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$762 in 10 payments from 7 companies in 2025. Trend: 2023 $574 · 2024 $392 · 2025 $762
Food & beverage: $762
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 1 | $130 |
| ARGENX US, INC. | 1 | $125 |
| Amgen Inc. | 1 | $124 |
| Teva Pharmaceuticals USA, Inc. | 1 | $123 |
| EMD Serono, Inc. | 2 | $101 |
| Tempus AI, Inc | 1 | $97 |
| ABBVIE INC. | 3 | $61 |
Products named: TREMFYA, VYVGART, AUSTEDO XR, XT CDX, SKYRIZI, RINVOQ.
Industry payments across CA — which companies pay providers there.
